An open-label phase 1/2a trial of a genetically modified rodent malaria parasite for immunization against Plasmodium falciparum malaria

Journal: Science Translational Medicine

Published: 2020-05-20

DOI: 10.1126/scitranslmed.aay2578

Affiliations: 7

Authors: 19

Go to article
Institutions Share
Radboud University Medical Centre (Radboudumc), RU, Netherlands 0.32
Erasmus University Medical Center (Erasmus MC), Netherlands 0.32
PATH, United States of America (USA) 0.21
University of Lisbon (ULISBOA), Portugal 0.16

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER